Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
English
|
|||||||||
oda_MaterialEventDisclosureGeneralAbstract|
|
|
||||||||
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
oda_AnnouncementContentSection|
|
|
||||||||
oda_ExplanationSection|
|
|
||||||||
oda_ExplanationTextBlock|
|
Operating in the field of animal health since 2005, our company acquired Arma İlaç Sanayi ve Ticaret A.Ş based on a strategic decision taken in 2021, thereby reinforcing its market position and becoming one of the leading companies in the market. In order to add a new investment to the ongoing investments of our company in the field of animal health, by our Board of Directors on the date of 27.04.2023; - A second production facility should be set up within the structure of Hektaş Ticaret Türk A.Ş. in the province of Ankara, to operate in the field of production of veterinary medicines, - As a result of the feasibility studies, the investment to be planed and budgeted total USD 48,000,000 (Forty eight Million USD), - The capacity of the products already produced should be increased by constructing the production facility to be set up in accordance with GMP standards - The product portfolio that is traded through the purchase and sale of commodities should be produced at its own production facilities - The product portfolio not currently available should be developed, and consequently, new market development should be ensured through different product groups by increasing effectiveness in both domestic and foreign markets, - Developments regarding the investment should be declared via KAP to our investors within the framework of the laws and regulations, - The General Directorate should be authorized for all kinds of transactions and businesses, in adherence to statutory legislative processes as well, specifically for the contracting companies and amounts determined with respect to the services requested within the scope of the investment, the decision has been taken.
In contradiction between the Turkish and English versions of this public disclosure, the Turkish version shall prevail. |
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.